NEW YORK — Navitas Semiconductor Corporation (NASDAQ: NVTS) shares skyrocketed more than 25% in morning trading Monday, reaching $22.79 as investors poured into the gallium nitride and silicon carbide power chip specialist amid booming demand for high-efficiency solutions in artificial intelligence data centers.
Navitas Semiconductor Stock Explodes 25% on Surging AI Data Center Demand and Strong Q1 Results
The semiconductor company, which specializes in next-generation GaNFast and GeneSiC power semiconductors, has emerged as one of the clearest pure-play beneficiaries of the AI infrastructure buildout. Monday’s surge pushed the stock well above recent trading ranges on heavy volume, reflecting renewed enthusiasm for companies enabling faster, cooler and more efficient power conversion in hyperscale data centers.
Q1 results fuel optimism
Navitas reported first-quarter 2026 results on May 5 that showed sequential revenue growth of 18% to $8.59 million, beating analyst expectations. The company highlighted a meaningful shift toward high-power markets, including AI data centers, grid infrastructure, and industrial electrification. Gross margins also expanded as the product mix improved.
CEO Chris Allexandre emphasized the company’s successful pivot away from lower-margin mobile markets toward higher-value AI and energy applications. Navitas guided for Q2 revenue between $10.0 million and $10.5 million, with continued margin expansion driven by its growing design-win pipeline now exceeding $2.4 billion.
Advertisement
AI power revolution drives momentum
The core catalyst for Navitas has been its leadership in gallium nitride (GaN) and silicon carbide (SiC) technologies. These materials allow for significantly more efficient power conversion than traditional silicon, reducing energy loss and heat generation — critical advantages as AI training clusters consume enormous amounts of electricity.
At NVIDIA’s GTC 2026 conference in March, Navitas showcased an innovative 800V-to-6V GaNFast power delivery board designed specifically for NVIDIA’s MGX platform. The demonstration underscored Navitas’ growing integration into next-generation AI infrastructure, sparking investor excitement about multi-year design wins with major hyperscalers.
Analysts note that AI data centers require unprecedented levels of power density and efficiency. Navitas’ solutions address exactly these challenges, positioning the company at the intersection of two of the most powerful secular trends in technology: artificial intelligence and energy efficiency.
Advertisement
Short squeeze and technical breakout
Monday’s explosive move also carried elements of a short squeeze. Navitas had been heavily shorted earlier in the year by investors skeptical of its transition strategy. As positive momentum built on strong guidance and product momentum, shorts were forced to cover, accelerating the upward spiral.
Technically, the stock has broken out of a multi-month consolidation pattern on significantly elevated volume, with analysts raising price targets in recent weeks. Some bullish voices now see potential for $30+ if execution continues and AI spending remains robust.
Company transformation story
Advertisement
Navitas has undergone a significant strategic shift over the past 18 months. Once heavily focused on consumer mobile charging, the company has successfully repositioned itself toward high-power applications. This “Navitas 2.0” strategy appears to be paying off as revenue from AI and industrial markets grows rapidly.
Recent governance enhancements, including the appointment of experienced independent directors, have also helped boost investor confidence. The company maintains a strong balance sheet and continues investing in R&D to maintain its technology edge.
Risks and valuation debate
Despite the enthusiasm, some analysts caution that the stock’s rapid rise leaves it vulnerable to pullbacks. Memory and power semiconductor stocks are historically cyclical, and any slowdown in AI capital expenditure could pressure results. At current levels, Navitas trades at premium multiples that assume continued hyper-growth.
Advertisement
However, many growth investors argue the valuation is justified given the massive addressable market and Navitas’ early-mover advantage in GaN and SiC for AI. The company’s expanding design-win pipeline provides some visibility into future revenue.
Broader semiconductor AI theme
Navitas’ surge fits into a larger narrative of AI infrastructure winners. Companies enabling efficient power delivery are increasingly seen as critical picks-and-shovels plays in the AI gold rush. Navitas joins peers benefiting from hyperscaler spending on data center expansion and next-generation computing.
What investors should watch
Advertisement
Going forward, key catalysts for Navitas include:
Q2 earnings in early August
Progress on major design wins converting to revenue
Updates from hyperscaler customers
Potential new product announcements at industry events
Monday’s dramatic move highlights how quickly sentiment can shift in the semiconductor sector when a company demonstrates clear momentum in a high-growth area like AI power electronics.
As trading continues, Navitas Semiconductor stands out as one of the most compelling — and volatile — stories in the 2026 semiconductor landscape. Whether the rally sustains depends on continued execution, but for now, investors are rewarding the company’s successful pivot to the heart of the AI revolution.
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call May 11, 2026 8:30 AM EDT
Company Participants
Harrison Aaron Michael Gorenstein – President, CEO & Chairman Anna Shlimak – Chief Financial Officer
Advertisement
Conference Call Participants
Kenric Tyghe – Canaccord Genuity Corp., Research Division William Kirk – ROTH Capital Partners, LLC, Research Division Derek Lessard – TD Cowen, Research Division Pablo Zuanic – Zuanic & Associates
Presentation
Advertisement
Operator
Good morning. My name is Michelle, and I will be your conference operator today. I would like to welcome everyone to the Cronos 2026 First Quarter Conference Call. Today’s call is being recorded.
At this time, I would like to turn the call over to Harrison Aaron, Senior Director, Investor Relations and Corporate Development. Please go ahead, sir.
Advertisement
Harrison Aaron
Thank you, Michelle, and thank you for joining us today to review Cronos’ 2026 Q1 financial and business performance. Today, I am joined by our Chairman, President and CEO, Mike Gorenstein; and our CFO, Anna Shlimak. Cronos issued a news release announcing our financial results this morning, which is filed on our EDGAR and SEDAR profiles. This information and the prepared remarks will also be posted on our website under Investor Relations.
Before I turn the call over to Mike, let me remind you that we may make forward-looking statements and refer to non-GAAP financial measures during this call. These forward-looking statements are based on management’s current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Factors that could cause actual results to differ materially from expectations are detailed in our earnings materials and our SEC filings that are available on our website, by which any forward-looking statements made during this call are qualified in their entirety.
An Indiana-based company is voluntarily recalling one of its dog food products due to potential salmonella contamination.
Albright’s Raw Pet Food of Fort Wayne is recalling one lot of its Chicken Recipe for Dogs Complete and Balanced product after routine sampling by the Food and Drug Administration found one composite sample testing positive for salmonella.
Advertisement
“While we continue to evaluate all available data, Albright’s Raw is proceeding with this voluntary recall to ensure the highest level of safety and transparency,” the company said in the recall notice.
Albright’s Raw Pet Food is based in Fort Wayne, Indiana. (Getty Images)
The recalled products are sold as frozen 1-pound bricks in clear vacuum packaging, and are generally distributed in 30-pound cases, the company said.
One lot of the product is affected and was sold directly to consumers nationwide and to select retailers in California, Massachusetts, North Carolina, New York, South Carolina and Wisconsin and by direct online sales.
Advertisement
The recalled products are sold as frozen 1-pound bricks in clear vacuum packaging. (iStock)
Albright’s Raw Pet Food said no illnesses associated with the affected lot have been confirmed or reported.
The company advises customers who have purchased the affected product not to feed it to pets and to throw it out or destroy it “in a way that children, pets, and wildlife cannot access it.” A receipt, pictures of the product and information on the place of purchase are required when requesting a refund.
A bag of Albright’s Raw Pet Food’s Chicken Recipe for Dogs Complete and Balanced. (FDA)
“Albright’s Raw is conducting further investigation on, including third-party laboratory testing, to better understand this finding,” the company said in the FDA notice. “We remain committed to producing safe, high-quality, biologically appropriate pet food and will continue to update our customers and partners as more information becomes available.”
Good morning, everyone, and welcome to the Kaltura First Quarter 2026 Earnings Call. All material contained in the webcast is the sole property and copyright of Kaltura with all rights reserved.
For opening remarks and introductions, I now turn the call over to Erica Mannion at Sapphire Investor Relations. Please go ahead, Erica.
Advertisement
Erica Mannion Sapphire Investor Relations, LLC
Thank you, operator, and good afternoon. I am joined by Ron Yekutiel, Kaltura’s Co-Founder, Chairman, President and Chief Executive Officer; and Liron Sharon, Executive Vice President of FP&A and Interim Principal Financial Officer. Ron will begin with a summary of the results for the first quarter ended March 31, 2026, and provide a business update. Liron will then review the financial results for the first quarter of 2026 in greater detail, followed by the company’s outlook for the second quarter and full year 2026. We will then open the call for questions.
Please note that this call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, statements regarding Kaltura’s expected future financial results, management’s expectations and plans for the business, including execution on our strategic transition and upcoming product launches, integration and expected benefits of our recent acquisitions, trends in customer engagement, anticipated headwinds and our expectations around capabilities and benefits of our products, including AI technologies. These statements are neither promises nor guarantees and involve risks and uncertainties that may cause actual results to differ materially from those discussed here. Important factors that could cause actual results to
US stocks have closed slightly higher, with AI optimism fuelling upward momentum even as the earnings-driven fervour of the recent rally eased in the home stretch of reporting season.
‘The Big Money Show’ panel reacts to Chicago Mayor Brandon Johnson forming a coalition of liberal mayors while facing rising debt costs and criticism over crime and federal funding demands.
Walgreens announced plans to close a location on Chicago’s South Side next month as the store’s profitability suffered due to elevated levels of theft as well as a decline in prescription sales.
The pharmacy chain revealed the reasons behind its decision to close the Walgreens at 86th in Cottage Grove in the Chatham neighborhood of Chicago at a town hall in the community on Saturday.
Advertisement
“I’m here today because we’re closing the store at 86th and Cottage Grove. But I just want to make sure everyone understands closing stores [is] not our goal. This is the last resort,” Walgreens regional Vice President Reginald Johnson said, according to Fox 32 Chicago.
Walgreens executives revealed at the town hall that the location lost over $1 million last year amid softening prescription sales and significant levels of theft, which resulted in the decision to close the store on June 4.
Walgreens is closing a location on Chicago’s South Side next month. (Jeffrey Greenberg/Universal Images Group via Getty Images)
Johnson said that “theft at this store is 16%,” which is “four times above the company average,” which contributed to losses at the store.
Advertisement
The company said that it took measures to counteract theft at the store, but was unable to put an end to the issues at the location.
“Lock boxes help us protect the merchandise in the store. A lot of the time, those lock boxes were getting destroyed. And that’s at a great cost to the company,” said Walgreens district manager Jason Vasquez, according to Fox 32’s report.
Walgreens executives said security and lock boxes weren’t sufficient to stop theft at the store. (Al Drago/Bloomberg via Getty Images)
It also said that Walgreens was spending $400,000 a year on security guards at the store, but employees still faced attacks and threats amid the theft at the location.
Advertisement
“Wev’e had people jump across the counters, because we sell liquor behind the counter, taking liquor, cigarettes,” said Lonnie Fuqua, the store’s manager. “That wears down. Not so much the financial piece but the endurance of that day in and day out.”
Residents and customers of the location expressed concern at the town hall about access to their prescriptions and frustration with having to go to a location farther away from their neighborhood, Fox 32 reported.
Walgreens is in the process of closing about 1,200 stores nationwide. (Lindsey Nicholson/UCG/Universal Images Group via Getty Images)
The company is encouraging customers to use another Walgreens location that’s about 1 mile away and is reaching out via mail and email to inform customers about how they can have their prescriptions delivered by mail.
Advertisement
“For seniors, there’s some solutions that have been put in place where you’ll get free delivery. That has already started for those medications you may have that, under the law, can be delivered,” Fuqua said.
You must be logged in to post a comment Login